The number of patients that overcomes breast cancer increases progressively thanks to early diagnosis and available treatments. However, once the disease is over, the women face the uncertainty that the tumor will reappear and the aftermath of the treatments. Currently, approximately 40% of patients suffer a relapse, which in more than half of the cases it occurs two or three years after the diagnosis.

A situation that, in the words of Dr. Laura García Estévez, of the Clara Campal Integral Oncology Center (CIOCC), is a "severe emotional blow" for patients, and more "when from the moment of diagnosis we transmit the possibility of cure. While it is true that in some cases, due to the type of tumor or lymph node involvement that has occurred, the risk of relapse is foreseeable, in others the tumor surprises us ".

How to cope with a recurrence, the adverse effects in the medium / long term of the treatments, or what are the factors that contribute to the patient and their environment feeling safe, are some of the topics related to the day to day of this disease that have been addressed during the symposium 'Living with breast cancer', celebrated in La Coruña.

This type of cancer is a disease that it has a strong emotional impact for the patient. However, there are women who, because of their own character, are stronger mentally, which together with a good family support means that they do not need to receive psychological help. Thus, for the president of the ADICAM Association of Cangas (Pontevedra), Josefa Acuña, "sharing experiences, information and desire to live with other people who have gone through the same is one of the best ways to cope with breast cancer "

The aftermath derived from the disease itself are multiple, whether physical, psychological, social or occupational, so it is essential the safety of the patient, a requirement that implies that, from the point of view of care, the correct compliance of all the diagnostic and therapeutic procedures and the patient is duly informed.

Source: EUROPE PRESS

Testing For Breast Cancer Recurrence (November 2019).